Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 25, 2015
From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa
Beau R Webber, Jakub Tolar
Journal for Immunotherapy of Cancer
|
December 26, 2025
Genetic engineering and allogeneic optimization of Vδ1 γδ CAR-T cells (ADI-270) for cancer immunotherapy
Wenlong Liu, Branden S Moriarity, Beau R Webber
Nature Biomedical Engineering
|
June 11, 2025
A pig with functional human immunity
Christopher K Tuggle, Crystal L Loving, Beau R Webber
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 23, 2024
Advancing gene targeting for primary immune deficiencies: Adenine base editing of the human IL2RG locus for correction of SCID-X1
R Scott McIvor, Ella J Eaton, Beau R Webber, et al.
Physical Biology
|
February 17, 2026
Mechanistic modeling predicts efficacy of CISH knockout in tumor-infiltrating lymphocytes with synergistic gene editing
Nikolaos Memmos, Kamran Kaveh, Beau R Webber, et al.
Biorxiv : the Preprint Server for Biology
|
September 18, 2025
Mathematical model of CISH knockout predicts increased efficacy in tumor-infiltrating lymphocyte activation with synergistic gene editing
Nikolaos Memmos, Kamran Kaveh, Beau R Webber, et al.
The Lancet. Oncology
|
July 31, 2025
CRISPR-engineered T-cell therapies: some clarifications needed - Authors' reply
Beau R Webber, Branden S Moriarity, Timothy K Starr, et al.
Scientific Reports
|
August 16, 2018
Engineering of Primary Human B cells with CRISPR/Cas9 Targeted Nuclease
Matthew J Johnson, Kanut Laoharawee, Walker S Lahr, et al.
Frontiers in Immunology
|
February 2, 2026
Correction: Perspective: IL-15 cytokine-armored NK cells as ready-to-use immunotherapy for diverse malignancies: therapeutic potential and toxicity risks
Scott L Baughan, Timothy Folsom, Matt Johnson, et al.
Blood
|
September 14, 2013
DNA methylation of Runx1 regulatory regions correlates with transition from primitive to definitive hematopoietic potential in vitro and in vivo
Beau R Webber, Michelina Iacovino, Si Ho Choi, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 25, 2015
From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa
Beau R Webber, Jakub Tolar
Journal for Immunotherapy of Cancer
|
December 26, 2025
Genetic engineering and allogeneic optimization of Vδ1 γδ CAR-T cells (ADI-270) for cancer immunotherapy
Wenlong Liu, Branden S Moriarity, Beau R Webber
Nature Biomedical Engineering
|
June 11, 2025
A pig with functional human immunity
Christopher K Tuggle, Crystal L Loving, Beau R Webber
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 23, 2024
Advancing gene targeting for primary immune deficiencies: Adenine base editing of the human IL2RG locus for correction of SCID-X1
R Scott McIvor, Ella J Eaton, Beau R Webber, et al.
Physical Biology
|
February 17, 2026
Mechanistic modeling predicts efficacy of CISH knockout in tumor-infiltrating lymphocytes with synergistic gene editing
Nikolaos Memmos, Kamran Kaveh, Beau R Webber, et al.
Biorxiv : the Preprint Server for Biology
|
September 18, 2025
Mathematical model of CISH knockout predicts increased efficacy in tumor-infiltrating lymphocyte activation with synergistic gene editing
Nikolaos Memmos, Kamran Kaveh, Beau R Webber, et al.
The Lancet. Oncology
|
July 31, 2025
CRISPR-engineered T-cell therapies: some clarifications needed - Authors' reply
Beau R Webber, Branden S Moriarity, Timothy K Starr, et al.
Scientific Reports
|
August 16, 2018
Engineering of Primary Human B cells with CRISPR/Cas9 Targeted Nuclease
Matthew J Johnson, Kanut Laoharawee, Walker S Lahr, et al.
Frontiers in Immunology
|
February 2, 2026
Correction: Perspective: IL-15 cytokine-armored NK cells as ready-to-use immunotherapy for diverse malignancies: therapeutic potential and toxicity risks
Scott L Baughan, Timothy Folsom, Matt Johnson, et al.
Blood
|
September 14, 2013
DNA methylation of Runx1 regulatory regions correlates with transition from primitive to definitive hematopoietic potential in vitro and in vivo
Beau R Webber, Michelina Iacovino, Si Ho Choi, et al.
Page
of 8